Page Six may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Kiss under the mistletoe or not, these pout products ...

Upgrade your winter routine with these seven skin-friendly retinol formulas that renew, firm and brighten without causing dryness or irritation. Winter naturally slows down your skin’s renewal process ...

The latest update for Notepad adds the ability to create and paste in tables, giving the text editor some expanded functionality for handling data. Microsoft is also upgrading Notepad's AI ...

Have you ever wondered what lies beyond the surface of the tools you use daily? Take Nano Banana Pro, for instance, a name synonymous with AI-driven creativity and productivity. While it’s already ...

When graphic design platform-provider Canva bought the Affinity image-editing and publishing apps early last year, we had some major questions about how the companies’ priorities and products would ...

Crispr Therapeutics (CRSP) is downgraded to "Hold" as current valuation already reflects optimism for CTX310 Phase I results and pipeline progress. Intellia Therapeutics (NTLA) maintains a "Buy" ...

If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. is a deputy editor with 18 years of experience writing and editing product reviews, gadgets and ...

A close partnership between academic institutions, industry, and the FDA helped develop within a record-breaking six months a personalized treatment designed to save the life of a baby. That’s a key ...

Google Tables, a work-tracking tool and competitor to the popular spreadsheet-database hybrid Airtable, is shutting down. In an email sent to Tables users this week, Google said the app will not be ...

If you do not intend to work with the template source code (and that means you will not be compiling it or running the Webpack dev server), you do not need to install anything. You can simply navigate ...

Gabriella Ngang, 18, of Farmington Hills is one of just three people in Michigan to take part in a clinical trial testing a new gene-editing therapy with the potential to cure her sickle cell disease.